Should You Buy Jasper Therapeutics Inc (JSPR) Stock on Monday?

The market has been high on Jasper Therapeutics Inc (JSPR) stock recently. JSPR gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Jasper Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on JSPR!

See Full JSPR Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With JSPR Stock Today?

Jasper Therapeutics Inc (JSPR) stock has risen 3.56% while the S&P 500 has fallen -0.03% as of 12:45 PM on Monday, Nov 27. JSPR is up $0.02 from the previous closing price of $0.66 on volume of 475,826 shares. Over the past year the S&P 500 is higher by 14.99% while JSPR is up 9.68%. JSPR lost -$0.83 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Jasper Therapeutics Inc click here.

More About Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Click Here to get the full Stock Report for Jasper Therapeutics Inc stock.